(MENAFN- America News Hour)
Research Nester published a report titled “Mesenchymal Stem Cells Market : Global Demand Analysis & Opportunity Outlook 2031” which delivers detailed overview of the global mesenchymal stem cells market in terms of market segmentation by type, source, application, and by region.
Further, for the in-depth analysis, the report encompasses the industry growth indicators, restraints, supply and demand risk, along with detailed discussion on current and future market trends that are associated with the growth of the market.
The global mesenchymal stem cells market is anticipated to attain a CAGR of ~5% over the forecast period, i.e., 2022 – 2031. The market is segmented by source into bone marrow, umbilical cord, adipose tissue, molar cells, and others. Out of these, the umbilical cord segment is anticipated to hold a substantial share over the forecast period on the back of the growing awareness amongst parents about the high regenerative properties of the umbilical cord cells. As a result, many parents store the umbilical cord cells for their child, in case they get any chronic disease in the future, which is estimated to boost the market growth.
Download Sample PDF Of This Report: –
The global mesenchymal stem cells market is estimated to grow on the back of increasing demand for regenerative treatment approach to treat deadly diseases, such as, cancer. In addition to this, growing amalgamation of technology in healthcare is leading to the development of various advanced medical devices and treatment methods, which is anticipated to fuel the market growth. Moreover, increasing prevalence of degenerative and rare diseases, including osteoporosis, cancer, spinal cord injuries, type 1 diabetes, Parkinson's disease , cartilage infection, and ischemic cardiac diseases, is estimated to boost the market growth. According to the data by the World Health Organization (WHO), in 2017 9 million people were suffering with type 1 diabetes.
On the basis of geographical analysis, the global mesenchymal stem cells market is segmented into five major regions including North America, Europe, Asia Pacific, Latin America and Middle East & Africa region. The market in the North America region is anticipated to gain the largest market share throughout the forecast period owing to the increasing adoption of advanced technology in healthcare sector, amongst the developed countries.
The research is global in nature and covers detailed analysis on the market in North America (U.S., Canada), Europe (U.K., Germany, France, Italy, Spain, Hungary, Belgium, Netherlands & Luxembourg, NORDIC [Finland, Sweden, Norway, Denmark], Poland, Turkey, Russia, Rest of Europe), Latin America (Brazil, Mexico, Argentina, Rest of Latin America), Asia-Pacific (China, India, Japan, South Korea, Indonesia, Singapore, Malaysia, Australia, New Zealand, Rest of Asia-Pacific), Middle East and Africa (Israel, GCC [Saudi Arabia, UAE, Bahrain, Kuwait, Qatar, Oman], North Africa, South Africa, Rest of Middle East and Africa). In addition, analysis comprising market size, Y-O-Y growth & opportunity analysis, market players' competitive study, investment opportunities, demand for future outlook etc. has also been covered and displayed in the research report.
Increasing Expenditure in Medical R&D Activities to Boost the Market Growth
Medical practitioners and scientists are increasingly adopting advance technology, such as, stem cell regeneration, to treat chronic ailments. The implementation of technology in medical industry is projected to generate growth opportunities for market growth. Along with this, the growing investment in research and development activities for healthcare sector is estimated to boost the market growth.
However, very high cost of stem cell treatment is expected to operate as key restraint to the growth of global mesenchymal stem cells market over the forecast period.
This report also provides the existing competitive scenario of some of the key players of the global mesenchymal stem cells market which includes company profiling of Merck Group, Genlantis Inc., Celprogen Inc., PromoCell GmbH, Cyagen Biosciences, Cytori Therapeutics Inc., Human Longevity Inc., Thermo Fisher Scientific, and Bio-Techne Corporation. The profiling enfolds key information of the companies which encompasses business overview, products and services, key financials and recent news and developments. On the whole, the report depicts detailed overview of the global mesenchymal stem cells market that will help industry consultants, equipment manufacturers, existing players searching for expansion opportunities, new players searching possibilities and other stakeholders to align their market centric strategies according to the ongoing and expected trends in the future.
Get a PDF Sample For More Detailed Market Insights:
Research Nester is a one-stop service provider, leading in strategic market research and consulting with an unbiased and unparalleled approach towards helping global industrial players, conglomerates and executives to make wise decisions for their future investment and expansion by providing them qualitative market insights and strategies while avoiding future uncertainties. We believe in honesty and sheer hard work that we trust is reflected in our work ethics. Our vision is not just limited to gain the trust of our clients but also to be equally respected by our employees and being appreciated by the competitors.
MENAFN05072022004545010068ID1104479485
Legal Disclaimer:
MENAFN provides the information “as is” without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the provider above.